Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: BoredMember who wrote (9508)	12/22/2017 4:04:45 PM
From: donpat	Read Replies (1) \| Respond to of 12873

I'll tell you a story, and not a sarcastic one at that. For 35 years in the patent business I would see the odd patent with a whole bunch of inventors listed, frequently from Russia. Those inventors got their glory and recognition in being listed on the patent! Not in the market place. The patent never made a dime. Patents that did do well had one or two or three inventors. I predict that NNVC will do well. That other version with all those assets you list will not. That, my dear friend, is from my personal experience. Now you can revert to bashing once more. Btw, what is your background that leads you to such silly conclusions?